Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F. Kennedy Jr. is involved ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
Corbus Pharmaceuticals presented new data from the first Western study of its antibody-drug conjugate treatment for cancer.
Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy ...
The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...
They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...
Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback